Related Experiment Video For Intraductal papillary mucinous neoplasm
Updated: May 23, 2026

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
Published on: April 17, 2026
Surgical indications and management of pancreatic cystic neoplasms
Riccardo Pellegrini1, Giampaolo Perri1, Giovanni Marchegiani1
1Hepato Pancreato Biliary and Liver Transplant Surgery, Department of Surgery, Oncology and Gastroenterology DiSCOG, University of Padova, Padua University Hospital, Via Giustiniani 2, 35128, Padova, Italy.
Abstract:
In recent years, the detection of pancreatic cystic neoplasms (PCNs) has significantly increased, revealing a spectrum of biologically distinct entities with widely variable malignant potential. In this complex and heterogeneous landscape, a multidisciplinary approach is essential not only to correctly identify lesions at risk of malignancy, but also to determine their appropriate therapeutic window, avoiding unnecessary resections of benign cysts while ensuring timely intervention before progression to invasive cancer. Despite the development of several guidelines worldwide, the rates of misdiagnosis and overtreatment remain high across all cysts subtypes, raising concerns about the appropriateness of current surgical indications. This is particularly relevant in the context of incidental detection of small cysts due to the widespread use of cross-sectional imaging. This review critically examines the current evidence and limitations in the surgical management of PCNs, highlighting the need for improved risk stratification tools and more individualized treatment strategies.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
